Shares of Psyence Biomedical Ltd. (Nasdaq: PBM) are popping, up 88% recently trading around $2.80 after swinging between $2.79 and $2.89 in today’s session, a notable move for a name that usually trades…
Immutep Limited (NASDAQ: IMMP) is exploding higher today, with shares up about 89% to 0.5961 on massive volume of over 614 million shares, versus an average of about…
Shares of Snail, Inc. (Nasdaq: $SNAL) are exploding higher today, recently changing hands at 1.2233—up more than 220% on the session—as a massive volume surge north…
Shares of Sky Quarry Inc. (NASDAQ: SKYQ) are jumping about 32% today as momentum traders continue to crowd into this thinly traded “waste‑to‑energy” story. The move extends…
Shares of Sky Quarry Inc. (Nasdaq: SKYQ) are on the move, up 46% after a multi‑day surge that has taken the stock from roughly $2.50 at the…
Shares of GameSquare Holdings, Inc. (Nasdaq: GAME) are ripping higher, up about 56–60% in early trading as the esports and creator‑economy company spikes from roughly $0.25 to about $0.40 on heavy…
Shares of Sleep Number Corporation (Nasdaq: SNBR) are bouncing hard, up about 36%, as traders cover shorts and bottom‑fish a name that has been pricing in severe…
Shares of HUB Cyber Security Ltd. (HUBC) are ripping higher, up about 60%, as speculative traders pile into the ultra‑beaten‑down name following its recent balance‑sheet overhaul and…
Shares of Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) are surging, up about 54%, as traders pile back into the beaten‑down solar manufacturer on renewed speculation around financing…
Shares of Biodexa Pharmaceuticals plc (Nasdaq: BDRX) are rallying, recently trading around $1.05, up roughly 70% on the day as heavy volume floods into this beaten‑down micro‑cap oncology name….
Shares of Predictive Oncology Inc. (Nasdaq: POAI) are surging, up about 109%, as a rush of speculative buying hits this ultra‑small‑cap AI‑driven oncology name. With the stock…
Shares of Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) are surging again, recently up about 60% as traders continue to pile into the ultra‑low‑float AI‑driven drug‑development name following…